Cathie Wood acquired 3.7M Apogee Therapeutics shares worth $493M. That's 3.22% of their equity portfolio (8th largest holding). The investor owns 6.02% of the outstanding Apogee Therapeutics stock. The stake costed the investor $237M, netting the investor a gain of 108% so far.